This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Duke University. Active years: 2013-2016.
Company Filing History:
Years Active: 2013-2016
Title: Innovations of Yasuhito Hamaguchi
Introduction
Yasuhito Hamaguchi is a notable inventor based in Kanazawa, Japan. He has made significant contributions to the field of immunotherapy, particularly in the development of antibodies for treating B cell disorders. With a total of 3 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
Hamaguchi's latest patents include "CD-20 specific antibodies and methods of employing same." This invention provides monoclonal antibodies and antigen-binding fragments that specifically bind to CD20, along with pharmaceutical compositions for depleting B cells or treating B cell disorders. Another significant patent is "Anti-CD19 antibodies and uses in B cell disorders." This invention relates to immunotherapeutic compositions for treating B cell diseases, utilizing therapeutic antibodies that bind to the human CD19 antigen. These patents highlight his innovative approach to addressing complex medical challenges.
Career Highlights
Yasuhito Hamaguchi is affiliated with Duke University, where he continues to advance his research in immunotherapy. His work has garnered attention for its potential applications in treating B cell malignancies and autoimmune diseases. His contributions to the field are recognized by peers and institutions alike.
Collaborations
Hamaguchi has collaborated with notable colleagues such as Thomas F. Tedder and Hanne Gron. These partnerships have further enriched his research and development efforts in the field of immunotherapy.
Conclusion
Yasuhito Hamaguchi's innovative work in the development of antibodies for B cell disorders showcases his commitment to advancing medical science. His patents reflect a dedication to improving treatment options for patients suffering from complex diseases.